logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Head And Neck Squamous Cell Carcinoma

    FiltersReset Filters
    5 results

    • beizray

      (Docetaxel)
      Zhuhai Beihai Biotech Co., Ltd.
      Usage: BEIZRAY, in combination with cisplatin and fluorouracil, is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

    • bleomycin

      (BLEOMYCIN SULFATE)
      Fresenius Kabi USA, LLC
      Usage: Bleomycin for Injection, USP is indicated for palliative treatment of various neoplasms, including squamous cell carcinoma (head and neck, penis, cervix, vulva), lymphomas (Hodgkin's and non-Hodgkin's), and testicular carcinoma (embryonal cell, choriocarcinoma, teratocarcinoma). It also helps manage malignant pleural effusion.

    • hydroxyurea

      (Hydroxyurea)
      Teva Pharmaceuticals USA, Inc.
      Usage: Hydroxyurea capsules are indicated for treating resistant chronic myeloid leukemia and for use in combination with chemoradiation for locally advanced squamous cell carcinomas of the head and neck (excluding the lip).

    • isoniazid

      (Isoniazid)
      Chartwell RX, LLC
      Usage: Isoniazid oral solution is indicated for treating all forms of susceptible tuberculosis, requiring multi-drug therapy to prevent resistance. It is also used for preventive therapy in high-risk groups, including HIV-infected individuals and close contacts of infectious cases, among others, to reduce tuberculosis incidence.

    • methotrexate

      (Methotrexate)
      Accord Healthcare, Inc.
      Usage: Methotrexate Injection is indicated for treating various conditions, including acute lymphoblastic leukemia, meningeal leukemia, Non-Hodgkin lymphoma, osteosarcoma, breast cancer, squamous cell carcinoma of the head and neck, gestational trophoblastic neoplasia, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and severe psoriasis.